149 related articles for article (PubMed ID: 23469650)
1. Thyroid function in patients with chronic hepatitis C virus infection under interferon therapy.
Abdel-Kader ME; Azmy MK; Hassan MA; Ahmad YK; El-Dahshan T; Houssein MA
J Egypt Soc Parasitol; 2012 Dec; 42(3):761-8. PubMed ID: 23469650
[TBL] [Abstract][Full Text] [Related]
2. Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study.
Bini EJ; Mehandru S
Arch Intern Med; 2004 Nov; 164(21):2371-6. PubMed ID: 15557418
[TBL] [Abstract][Full Text] [Related]
3. Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?
Kozielewicz D; Zaleśna A; Dybowska D
Expert Opin Drug Saf; 2014 Aug; 13(8):1009-14. PubMed ID: 24930451
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal study of antibodies against thyroid in patients undergoing interferon-alpha therapy for HCV chronic hepatitis.
Carella C; Amato G; Biondi B; Rotondi M; Morisco F; Tuccillo C; Chiuchiolo N; Signoriello G; Caporaso N; Lombardi G
Horm Res; 1995; 44(3):110-4. PubMed ID: 7590640
[TBL] [Abstract][Full Text] [Related]
5. Virus C genotype predisposes to primary hypothyroidism during interferon-α treatment for chronic hepatitis C.
Pavan MH; Pavin EJ; Gonçales FL; Zantut-Wittmann DE; Wittmann DE
Braz J Infect Dis; 2011; 15(5):449-56. PubMed ID: 22230851
[TBL] [Abstract][Full Text] [Related]
6. Incidence of dysthyroidism during interferon therapy in chronic hepatitis C.
Benelhadj S; Marcellin P; Castelnau C; Colas-Linhart N; Benhamou JP; Erlinger S; Bok B
Horm Res; 1997; 48(5):209-14. PubMed ID: 9362390
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
[TBL] [Abstract][Full Text] [Related]
8. [Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
Teng ZL; Gong WJ; Zhang SQ; Sun YX; Ma XH
Zhonghua Gan Zang Bing Za Zhi; 2013 Feb; 21(2):101-4. PubMed ID: 23663880
[TBL] [Abstract][Full Text] [Related]
9. [Thyroid dysfunctions in children with chronic hepatitis C during interferon alpha-2b therapy].
Kupś-Rzepecka J; Woźniakowska-Gesicka T; Gołabek V
Przegl Lek; 2011; 68(6):311-5. PubMed ID: 22039668
[TBL] [Abstract][Full Text] [Related]
10. Evaluated reference intervals for serum free thyroxine and thyrotropin using the conventional outliner rejection test without regard to presence of thyroid antibodies and prevalence of thyroid dysfunction in Japanese subjects.
Takeda K; Mishiba M; Sugiura H; Nakajima A; Kohama M; Hiramatsu S
Endocr J; 2009; 56(9):1059-66. PubMed ID: 19738362
[TBL] [Abstract][Full Text] [Related]
11. Reference ranges of serum TSH, FT4 and thyroid autoantibodies in the Thai population: the national health examination survey.
Sriphrapradang C; Pavarangkoon S; Jongjaroenprasert W; Chailurkit LO; Ongphiphadhanakul B; Aekplakorn W
Clin Endocrinol (Oxf); 2014 May; 80(5):751-6. PubMed ID: 24266630
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of thyroid dysfunction and influencing factors in chronic hepatitis C patients treated with peg-IFNa-2a and ribavirin].
Huang YX; Chen XY; Ma LN; Yin JM; Ren S; Guo DD; Zheng YH
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):216-20. PubMed ID: 22475143
[TBL] [Abstract][Full Text] [Related]
13. Patterns of interferon-alpha-induced thyroid dysfunction vary with ethnicity, sex, smoking status, and pretreatment thyrotropin in an international cohort of patients treated for hepatitis C.
Mammen JS; Ghazarian SR; Rosen A; Ladenson PW
Thyroid; 2013 Sep; 23(9):1151-8. PubMed ID: 23517287
[TBL] [Abstract][Full Text] [Related]
14. Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Serranti D; Indolfi G; Nebbia G; Cananzi M; D'Antiga L; Ricci S; Stagi S; Azzari C; Resti M;
Pediatr Infect Dis J; 2018 Apr; 37(4):287-291. PubMed ID: 28953189
[TBL] [Abstract][Full Text] [Related]
15. Multiple changes in thyroid function in patients with chronic active HCV hepatitis treated with recombinant interferon-alpha.
Roti E; Minelli R; Giuberti T; Marchelli S; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Neri TM; Braverman LE
Am J Med; 1996 Nov; 101(5):482-7. PubMed ID: 8948271
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of abnormal thyrotropin concentrations measured by a sensitive assay in patients with type 2 diabetes mellitus.
Celani MF; Bonati ME; Stucci N
Diabetes Res; 1994; 27(1):15-25. PubMed ID: 7648793
[TBL] [Abstract][Full Text] [Related]
17. Effects of excess iodine administration on thyroid function in euthyroid patients with a previous episode of thyroid dysfunction induced by interferon-alpha treatment.
Minelli R; Braverman LE; Giuberti T; Schianchi C; Gardini E; Salvi M; Fiaccadori F; Ugolotti G; Roti E
Clin Endocrinol (Oxf); 1997 Sep; 47(3):357-61. PubMed ID: 9373459
[TBL] [Abstract][Full Text] [Related]
18. Prospective observation of 5-year clinical course of subclinical hypothyroidism in korean population.
Park WR; Oh TK; Jeon HJ
J Korean Med Sci; 2013 Nov; 28(11):1622-6. PubMed ID: 24265525
[TBL] [Abstract][Full Text] [Related]
19. A rare case of Interferon-alpha-Induced Hyperthyroidism in patients with a chronic hepatitis C with granulocytopenia and transaminasemia treated successfully with radioiodine.
Czarnywojtek A; Waligórska-Stachura J; Szczepanek E; Zgorzalewicz-Stachowiak M; Bereszyńska I; Kurdybacha P; Stangierski A; Harasymczuk J; Florek E; Waśko R; Ruchała M
Neuro Endocrinol Lett; 2012; 33(3):268-72. PubMed ID: 22635082
[TBL] [Abstract][Full Text] [Related]
20. Peginterferon Lambda-1a Is Associated with a Low Incidence of Autoimmune Thyroid Disease in Chronic Hepatitis C.
Fredlund P; Hillson J; Gray T; Shemanski L; Dimitrova D; Srinivasan S
J Interferon Cytokine Res; 2015 Nov; 35(11):841-3. PubMed ID: 26376344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
